Literature DB >> 16912258

European move affects academic trials research.

Gunjan Sinha.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16912258     DOI： 10.1093/jnci/djj349

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Investigator-initiated trials of targeted oncology agents: why independent research is at risk?

Authors:  L Bergmann; B Berns; A G Dalgleish; M von Euler; T T Hecht; G L Lappin; N Reed; S Palmeri; J Smyth; S Embacher-Aichorn; H Zwierzina
Journal:  Ann Oncol       Date:  2010-02-04       Impact factor: 32.976

2.  Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation.

Authors:  Benjamin Speich; Nadine Schur; Dmitry Gryaznov; Belinda von Niederhäusern; Lars G Hemkens; Stefan Schandelmaier; Alain Amstutz; Benjamin Kasenda; Christiane Pauli-Magnus; Elena Ojeda-Ruiz; Yuki Tomonaga; Kimberly McCord; Alain Nordmann; Erik von Elm; Matthias Briel; Matthias Schwenkglenks
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

3.  The unintended consequences of clinical trials regulations.

Authors:  Alex D McMahon; David I Conway; Tom M Macdonald; Gordon T McInnes
Journal:  PLoS Med       Date:  2009-11-17       Impact factor: 11.069

4.  Practices and Attitudes of Swiss Stakeholders Regarding Investigator-Initiated Clinical Trial Funding Acquisition and Cost Management.

Authors:  Stuart McLennan; Alexandra Griessbach; Matthias Briel
Journal:  JAMA Netw Open       Date:  2021-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.